Latest filing published 18 Mar 2016 for Capricor Therapeutics, INC., €900k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +12.7%Entry US$27.50 · Close at T+365 US$31.00
- -60.8%Entry US$58.20 · Close at T+365 US$22.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Edward A. St. John: trading record in brief
Edward A. St. John discloses dealings in Capricor Therapeutics, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 21 January 2015 and the latest from 16 March 2016.
Every open-market trade on record is a purchase: 4 purchases worth €4.4M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2016 to date brings 2 purchases and no sales.
A typical purchase (the median) is worth €1.1M.
The record was last updated on 18 March 2016 with an open-market purchase (€900k) in Capricor Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Edward A. St. John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 416,666 shares@ US$2.40100.0% of flowCommon StockSEC:0001144204-16-088987:0Canonical exit: 14 Jun 2016 (T+90)
- 425,773 shares@ US$3.523Common StockSEC:0001144204-15-003580:0Canonical exit: 21 Apr 2015 (T+90)
2 of 2 declarations
